Alzheimers therapy (Cambridge NeuroScience/Gladstone Institute)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameAlzheimers therapy (Cambridge NeuroScience/Gladstone Institute)
Drug Alias NameApoE inhibitor (Cambridge Neuroscience/Gladstone)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipid metabolism modulators
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCambridge NeuroScience Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Gladstone Institute of Cardiovascular DiseaseCeNeS Pharmaceuticals plcCambridge NeuroScience Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A